Pharmacom Financial Statements From 2010 to 2026
| PHMB Stock | USD 0.0001 0.00 0.00% |
Check Pharmacom Biovet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmacom Biovet's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharmacom financial statements analysis is a perfect complement when working with Pharmacom Biovet Valuation or Volatility modules.
Pharmacom | Build AI portfolio with Pharmacom Stock |
Pharmacom Biovet Company Current Valuation Analysis
Pharmacom Biovet's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Pharmacom Biovet Current Valuation | 1.08 M |
Most of Pharmacom Biovet's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmacom Biovet is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Pharmacom Biovet has a Current Valuation of 1.08 M. This is 99.99% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Pharmacom Biovet Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmacom Biovet's current stock value. Our valuation model uses many indicators to compare Pharmacom Biovet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmacom Biovet competition to find correlations between indicators driving Pharmacom Biovet's intrinsic value. More Info.Pharmacom Biovet is rated below average in current valuation category among its peers. It is considered to be number one stock in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmacom Biovet's earnings, one of the primary drivers of an investment's value.About Pharmacom Biovet Financial Statements
Pharmacom Biovet stakeholders use historical fundamental indicators, such as Pharmacom Biovet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pharmacom Biovet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharmacom Biovet's assets and liabilities are reflected in the revenues and expenses on Pharmacom Biovet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharmacom Biovet. Please read more on our technical analysis and fundamental analysis pages.
PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. PharmaCom BioVet, Inc. was incorporated in 1995 and is headquartered in Raleigh, North Carolina. PHARMACOM BIOVET operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out the analysis of Pharmacom Biovet Correlation against competitors. For information on how to trade Pharmacom Stock refer to our How to Trade Pharmacom Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmacom Biovet. If investors know Pharmacom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmacom Biovet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmacom Biovet is measured differently than its book value, which is the value of Pharmacom that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmacom Biovet's value that differs from its market value or its book value, called intrinsic value, which is Pharmacom Biovet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmacom Biovet's market value can be influenced by many factors that don't directly affect Pharmacom Biovet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmacom Biovet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmacom Biovet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmacom Biovet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.